Vγ9Vδ2 T-cells are potent inhibitors of SARS-CoV-2 replication and represent effector phenotypes in COVID-19 patients.
Gay L, Rouviere MS, Mezouar S, Richaud M, Gorvel L, Foucher E, La Scola B, Menard A, Allardet-Servent J, Halfon P, Frohna P, Cano C, Mege JL, Olive D.
Gay L, et al. Among authors: halfon p.
J Infect Dis. 2024 Apr 1:jiae169. doi: 10.1093/infdis/jiae169. Online ahead of print.
J Infect Dis. 2024.
PMID: 38557809